Trial intelligence / Profile preview

PROPHESY: PCC vs FFP in Heart Surgery

NCT03715348Phase 2Completed

Sponsor
Queen Mary University of London
Start
Mar 2019
Primary completion
Jan 2020
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of prothrombin complex concentrate, human in hemorrhage, sponsored by Queen Mary University of London. Started Mar 2019; status: completed.

02

Drugs

prothrombin complex concentrate, human
03

Conditions

hemorrhage

Beyond the preview

Go deeper on NCT03715348.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03715348.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call